ANI Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

ANI Pharmaceuticals (NASDAQ:ANIP) has announced its participation in two upcoming investor conferences. CEO Nikhil Lalwani and the executive team will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 9:00 AM ET, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, at 1:50 PM ET.

Investors can access both live and archived webcasts through the company's website at www.anipharmaceuticals.com in the Investors section under Events and Presentations. The webcast replays will remain available for 90 days.

News Market Reaction – ANIP

+1.74%

+1.74% Session close to close

In the Aug 26 session, ANIP gained 1.74%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team will present at two upcoming investor conferences as follows:

EVENT: H.C. Wainwright 27th Annual Global Investment Conference
DATE: Monday, September 8, 2025
TIME: 9:00am ET

EVENT: Morgan Stanley 23rd Annual Global Healthcare Conference
DATE: Tuesday, September 9, 2025
TIME: 1:50pm ET

The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When is ANI Pharmaceuticals (ANIP) presenting at the H.C. Wainwright Conference 2025?

ANI Pharmaceuticals will present at the H.C. Wainwright Conference on Monday, September 8, 2025 at 9:00 AM ET.

When is ANI Pharmaceuticals (ANIP) presenting at the Morgan Stanley Healthcare Conference 2025?

ANI Pharmaceuticals will present at the Morgan Stanley Healthcare Conference on Tuesday, September 9, 2025 at 1:50 PM ET.

Who will be presenting at the upcoming ANI Pharmaceuticals investor conferences?

Nikhil Lalwani, President and Chief Executive Officer, along with members of the company's executive leadership team will be presenting.

How can investors access ANI Pharmaceuticals' conference presentations?

Investors can access both live and archived webcasts through www.anipharmaceuticals.com in the Investors section under Events and Presentations. Replays will be available for 90 days.